CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,612,000 | -3.7% | 13,099,000 | 0.0% | 0.18% | +5.4% |
Q2 2022 | $9,986,000 | +20.8% | 13,099,000 | 0.0% | 0.17% | +75.0% |
Q1 2022 | $8,268,000 | -18.2% | 13,099,000 | 0.0% | 0.10% | -6.8% |
Q4 2021 | $10,108,000 | -14.1% | 13,099,000 | 0.0% | 0.10% | -22.6% |
Q3 2021 | $11,770,000 | -14.6% | 13,099,000 | 0.0% | 0.13% | -36.1% |
Q2 2021 | $13,780,000 | -7.3% | 13,099,000 | 0.0% | 0.21% | -43.8% |
Q1 2021 | $14,861,000 | +27.0% | 13,099,000 | 0.0% | 0.37% | +103.3% |
Q4 2020 | $11,702,000 | -8.5% | 13,099,000 | 0.0% | 0.18% | -30.8% |
Q3 2020 | $12,793,000 | – | 13,099,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 64,842,000 | $63,520,000 | 3.42% |
QVT Financial LP | 15,000,000 | $14,638,000 | 1.79% |
ARISTEIA CAPITAL, L.L.C. | 22,150,000 | $21,214,000 | 0.87% |
WHITEBOX ADVISORS LLC | 9,300,000 | $8,861,000 | 0.37% |
LMR Partners LLP | 13,099,000 | $12,793,000 | 0.26% |
CAPSTONE INVESTMENT ADVISORS, LLC | 6,100,000 | $5,842,000 | 0.03% |
WOLVERINE ASSET MANAGEMENT LLC | 1,500,000 | $1,442,000 | 0.01% |
WELLS FARGO & COMPANY/MN | 2,025,000 | $1,982,000 | 0.00% |
DEUTSCHE BANK AG\ | 1,968,000 | $1,875,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |